GENEDX HOLDINGS CORP. |
Market Closed -
Other stock markets
|
After market 06:18:48 pm | |||
| 11 USD | -0.72% |
|
14.2 | +29.09% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 20,163 | 1,076 | 102 | 71.18 | 288.7 | - | - |
| Enterprise Value (EV) 1 | 20,163 | 1,076 | -15.65 | -6.278 | 315.8 | 297.6 | 286.5 |
| P/E ratio | -2.94 x | -1.96 x | -0.16 x | -0.38 x | -2.27 x | -3.2 x | - |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 5.07 x | 0.43 x | 0.35 x | 1.28 x | 1.09 x | 0.91 x |
| EV / Revenue | - | 5.07 x | -0.07 x | -0.03 x | 1.4 x | 1.13 x | 0.91 x |
| EV / EBITDA | - | -5.39 x | 0.06 x | 0.07 x | -6.19 x | -20.5 x | 6.36 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 55,344 | 7,311 | 11,721 | 25,884 | 26,054 | - | - |
| Reference price 2 | 364.3 | 147.2 | 8.705 | 2.750 | 11.08 | 11.08 | 11.08 |
| Announcement Date | 5/6/21 | 3/14/22 | 3/14/23 | 2/20/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 212.2 | 234.7 | 202.6 | 226.1 | 264.3 | 316.3 |
| EBITDA 1 | - | -199.6 | -266.7 | -94.56 | -51 | -14.53 | 45.04 |
| EBIT 1 | - | -221.4 | -326 | -128.3 | -50.22 | -15.37 | 15.56 |
| Operating Margin | - | -104.34% | -138.93% | -63.34% | -22.21% | -5.81% | 4.92% |
| Earnings before Tax (EBT) | - | -245.4 | -598 | - | - | - | - |
| Net income 1 | -39,908 | -245.4 | -549 | -175.8 | -135.9 | -106.6 | - |
| Net margin | - | -115.64% | -233.91% | -86.77% | -60.11% | -40.34% | - |
| EPS 2 | -123.8 | -74.91 | -53.79 | -7.230 | -4.890 | -3.460 | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 5/6/21 | 3/14/22 | 3/14/23 | 2/20/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 43.18 | 57.8 | 53.94 | 36.17 | 83.23 | 61.35 | 43.14 | 48.71 | 53.3 | 57.42 | 49.45 | 55.05 | 58.27 | 63.33 | 54.4 |
| EBITDA 1 | -65.89 | -73.02 | -58.88 | -115 | -70.05 | -38.7 | -40.22 | -43.12 | -22.38 | -11.11 | -22.55 | -18 | -13.6 | -9.1 | -13.15 |
| EBIT 1 | -71.38 | -78.81 | -64.68 | -121.7 | -77.04 | -72.74 | -48.86 | -51.62 | -31.05 | -17.2 | -16.95 | -14.01 | -11.13 | -8.005 | -5 |
| Operating Margin | -165.31% | -136.35% | -119.91% | -336.37% | -92.56% | -118.57% | -113.26% | -105.99% | -58.25% | -29.96% | -34.28% | -25.45% | -19.1% | -12.64% | -9.19% |
| Earnings before Tax (EBT) | 31.39 | -40.18 | -76.9 | -134.8 | -77.65 | -308.7 | - | - | - | - | - | - | - | - | - |
| Net income 1 | 31.39 | -40.18 | -76.9 | -85.74 | -77.58 | -308.8 | -60.99 | -46.72 | -42.29 | -25.77 | -41.7 | -36.8 | -31.5 | -25.9 | -38.2 |
| Net margin | 72.7% | -69.52% | -142.56% | -237.06% | -93.21% | -503.28% | -141.38% | -95.92% | -79.33% | -44.89% | -84.32% | -66.85% | -54.06% | -40.9% | -70.22% |
| EPS 2 | 4.950 | -5.610 | -10.23 | -8.250 | -6.600 | -29.04 | -3.040 | -1.840 | -1.640 | -0.9200 | -1.550 | -1.340 | -1.110 | -0.8900 | -1.270 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 11/15/21 | 3/14/22 | 5/12/22 | 8/15/22 | 11/14/22 | 3/14/23 | 5/9/23 | 8/8/23 | 10/30/23 | 2/20/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | 27.1 | 8.94 | - |
| Net Cash position 1 | - | - | 118 | 77.5 | - | - | 2.2 |
| Leverage (Debt/EBITDA) | - | - | - | - | -0.5313 x | -0.615 x | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex | - | 9.4 | - | - | - | - | - |
| Capex / Sales | - | 4.43% | - | - | - | - | - |
| Announcement Date | 5/6/21 | 3/14/22 | 3/14/23 | 2/20/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
11.08
USD
Average target price
11.38
USD
Spread / Average Target
+2.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +300.00% | 289M | |
| -16.58% | 8.25B | |
| +40.93% | 3.58B | |
| -35.59% | 2.46B | |
| -7.88% | 2.46B | |
| -8.95% | 2.38B | |
| -5.93% | 1.81B | |
| -18.96% | 1.55B | |
| -38.35% | 1.21B | |
| +6.91% | 1.11B |
- Stock Market
- Equities
- WGS Stock
- Financials GeneDx Holdings Corp.
